QUESTION FOUR $[25]$

Delta Pharmaceuticals is a mid$-$sized pharmaceutical company specializing in the development and

production of generic medications. With a focus on affordable healthcare solutions, Delta

Pharmaceuticals operates in a competitive market, facing challenges such as patent expirations,

regulatory changes, and evolving customer demands. The company seeks to develop a

comprehensive strategy to drive growth, enhance competitiveness, and ensure long$-$term

sustainability.

Currently Delta Pharmaceuticals faces several challenges that necessitate strategic planning that

include the following:

$$ Market Competition: Intense competition from other generic drug manufacturers and

emerging players.

$$ Regulatory Environment: Evolving regulatory landscape affecting product approvals, pricing,

and market access.

$$ Innovation and Differentiation: Need to innovate and differentiate products to stand out in the

market.

$$ Global Expansion: Opportunities to expand into new markets while managing risks

associated with international operations.

$$ Cost Efficiency: Pressure to maintain cost efficiency in research, development, and

production processes.

Delta Pharmaceuticals have appointed you to develop a strategy that include the following

objectives:

$$ Achieve sustainable revenue growth through product diversification and market expansion.

$$ Enhance brand recognition and customer loyalty through innovative product offerings.

$$ Optimize operational efficiency to reduce costs and improve profitability.

$4$

$$ Expand into new geographic markets while ensuring regulatory compliance.

$$ Develop a robust pipeline of new generic medications to capitalize on market opportunities.

Required:

Identify the steps in the strategy development process and suggest key strategic objectives that

need to be addressed.